Court of Appeal says in-house representatives can appear before the court | Patent attorneys with ‘administrative and ...

Nominations open as D&I values face growing backlash on both sides of the pond | Research shows equality efforts result in ...

2 January 2024 District judge ruled in favour of Regeneron confirming patent infringement by Mylan | Court recognised Mylan's ...

20 October 2022 Commission overturns one ALJ finding but affirms all others, agreeing that Wuhan Healthgen infringed Ventria's rice seed patent | Dispute concerns recombinant human proteins derived ...

4 February 2025 Former DLA Piper partner Melissa Harwood joins firm’s chemistry and life sciences team | Brings experience in biotechnology, therapeutics, and chemical industries.

24 January 2025 New recruit brings expertise in developing and prosecuting complex patent portfolios for small molecule drug products | Partner joins from New York law firm Fenwick & West.

Whoop faces suit over tech in health tracker watch ...

LSIPR sister title releases USA Patents Rankings, divided into categories of non-contentious and contentious work | Listing ...

29 August 2024 Regeneron accused the Swiss pharma company of infringing a slew of patents related to Eylea and violating the ...

Oral hearings heard the USPTO side with MSD (Merck) over a term extension for a reissued patent, in a case set to have huge implications for pharma market exclusivity, reports Marisa Woutersen.

If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.